AMBIT BIOSCIENCES
Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pha... rma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.
AMBIT BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2000-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ambitbio.com
Total Employee:
51+
Status:
Active
Contact:
(858) 334-2100
Email Addresses:
[email protected]
Total Funding:
215.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box Organization Schema
Similar Organizations
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Apposite Capital
Apposite Capital investment in Venture Round - Ambit Biosciences
Radius Ventures
Radius Ventures investment in Venture Round - Ambit Biosciences
Roche Venture Fund
Roche Venture Fund investment in Venture Round - Ambit Biosciences
GrowthWorks Capital
GrowthWorks Capital investment in Venture Round - Ambit Biosciences
Gimv
Gimv investment in Venture Round - Ambit Biosciences
Forward Ventures
Forward Ventures investment in Venture Round - Ambit Biosciences
Aisling Capital
Aisling Capital investment in Venture Round - Ambit Biosciences
MedImmune Ventures
MedImmune Ventures investment in Venture Round - Ambit Biosciences
OrbiMed
OrbiMed investment in Venture Round - Ambit Biosciences
Forward Ventures
Forward Ventures investment in Series D - Ambit Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-09-19 | Afraxis | Ambit Biosciences investment in Series A - Afraxis | 1.5 M USD |
Official Site Inspections
http://www.ambitbio.com
- Host name: 172.67.160.111
- IP address: 172.67.160.111
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
